Well being Canada says that AstraZeneca COVID-19 vaccines produced in Baltimore plant — which was positioned underneath investigation by U.S. Meals and Drug Administration (FDA) earlier this month — are all protected and of “prime quality.”
Canada to see 1st Johnson & Johnson shipments subsequent week, however no extra till June
In a press release Sunday, the nation’s well being company mentioned that the 1.5 million doses of AstraZeneca vaccines imported to Canada from Emergent BioSolutions’ Baltimore facility met high quality specs and have been protected to make use of.
The assertion comes after AstraZeneca and Johnson & Johnson’s vaccines from the ability have been halted by the FDA earlier this month with the intention to examine an error that led to tens of millions of doses of J&J’s vaccine being ruined in March.
Canada surpasses 12 million COVID-19 vaccine jabs as rollout picks up pace
Oscars 2021 winners: ‘Nomadland’ wins greatest image in distinctive awards ceremony
Challenges going through Canada to get some COVID-19 restrictions lifted by summer season
“Canadians may be assured that Well being Canada is taking all vital steps to make sure that any merchandise coming from this facility will solely be used if they’re protected and efficient,” learn the assertion.
Well being Canada additionally verified that the 300,000 doses of the J&J vaccine, that are anticipated to return into Canada subsequent week, don’t come from the Baltimore facility.
View hyperlink »
© 2021 World Information, a division of Corus Leisure Inc.